Targeting CXCR4-induced Desmoplasia to Improve Checkpoint Inhibition in Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1900368116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

The Complexities of Breast Cancer Desmoplasia

Breast Cancer Research
Cancer ResearchOncology
2001English

CXCR4-targeted Therapy in Breast Cancer

The Lancet Oncology
Oncology
2018English

Targeting the CXCL12/CXCR4 Pathway and Myeloid Cells to Improve Radiation Treatment of Locally Advanced Cervical Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Targeting Checkpoint Kinase 1 in Cancer Therapeutics

Clinical Cancer Research
Cancer ResearchOncology
2007English

Immune Checkpoint Inhibition in Head and Neck Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Targeting Invadopodia to Block Breast Cancer Metastasis

Oncotarget
Oncology
2011English

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Oncotarget
Oncology
2014English

Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition

Oncotarget
Oncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy